Insulet Corporation (PODD) PT Raised to $300 at Stifel After Omnipod 5 Pivotal Study Data
Tweet Send to a Friend
Stifel analyst Matthew Blackman raised the price target on Insulet Corporation (NASDAQ: PODD) to $300.00 (from $270.00) after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
